Structure Therapeutics | 10-Q: Q3 2024 Earnings Report
Structure Therapeutics | 8-K: Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights First patients dosed in Phase 2b ACCESS study of GSBR-1290 for obesity
Structure Therapeutics | 10-Q: Q2 2024 Earnings Report
Structure Therapeutics | 8-K: Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights
Structure Therapeutics | 8-K: Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
Structure Therapeutics | 10-Q: Q1 2024 Earnings Report
Structure Therapeutics | 10-K: FY2023 Annual Report
Structure Therapeutics | 8-K: Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights
Structure Therapeutics | 10-Q: Q3 2023 Earnings Report
Structure Therapeutics | 10-Q/A: Q3 2022 Earnings Report
Structure Therapeutics | 10-Q/A: Quarterly report (Amendment)
Structure Therapeutics | 8-K: Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
Structure Therapeutics | 10-Q: Quarterly report
Structure Therapeutics | 8-K: Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights
Structure Therapeutics | 10-Q: Quarterly report
Structure Therapeutics | 8-K: Structure Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights
Structure Therapeutics | 10-K: FY2022 Annual Report
Structure Therapeutics | 8-K: Structure Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
No Data
No Data